Dergiler / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 4

The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B

Sayfa
411–415
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There was no significant difference between HAI and fibrosis group with regard to GGT levels in the hepatitis C patients.Conclusion: In conclusion, it is proposed that in patients with chronic viral hepatitis, GGT levels can be taken into consideration to predict advanced histological liver damage, especially in patients with hepatitis B

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: To investigate the relationship between gamma-glutamyl transpeptidase (GGT) levels and histopathological status determined by biopsy in patients with chronic hepatitis B and C.Materials and Methods: Patients with chronic hepatitis B and C who were referred to the Uludağ University Faculty of Medicine Gastroenterology outpatient clinic between January 2005-January 2011 and underwent liver biopsy were included in the study.
📊
Temel Bulgular & Veri:Overall, 246 patients with hepatitis B and 151 patients with hepatitis C were enrolled.
💡
Sonuç & Katkı:There was no significant difference between HAI and fibrosis group with regard to GGT levels in the hepatitis C patients.Conclusion: In conclusion, it is proposed that in patients with chronic viral hepatitis, GGT levels can be taken into consideration to predict advanced histological liver damage, especially in patients with hepatitis B
🔬Tür:Araştırma Makalesi
📍Kapsam:2005 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: To investigate the relationship between gamma-glutamyl transpeptidase (GGT) levels and histopathological status determined by biopsy in patients with chronic hepatitis B and C.Materials and Methods: Patients with chronic hepatitis B and C who were referred to the Uludağ University Faculty of Medicine Gastroenterology outpatient clinic between January 2005-January 2011 and underwent liver biopsy were included in the study. Overall, 246 patients with hepatitis B and 151 patients with hepatitis C were enrolled. According to the evaluation based on the Ishak score, patients with a histological activity index (HAI) between 0-12 were defined as low activity, and those with an HAI between 13-18 were defined as high activity. In addition, patients with a fibrosis score of 0-2 were defined as low fibrosis, and those with a score between 3-6 were defined as high fibrosis; comparisons were made accordingly.Results: In patients with hepatitis B, the mean GGT level was 38.86±42.4 (IU/L) in the low activity group and 60.44±44.4 (IU/L) in the high activity group (p<0.05). In hepatitis B patients, the mean GGT level was 26.89±14.83 (IU/L) in the low fibrosis group, whereas it was 65.60±59.7 (IU/L) in the high fibrosis group (p<0.001). There was no significant difference between HAI and fibrosis group with regard to GGT levels in the hepatitis C patients.Conclusion: In conclusion, it is proposed that in patients with chronic viral hepatitis, GGT levels can be taken into consideration to predict advanced histological liver damage, especially in patients with hepatitis B

🔖

Bu Makaleye Atıf Yap

EMİNLER, A. T., IRAK, K., AYYILDIZ, T., KESKİN, M., KIYICI, M., GÜREL, S., GÜLTEN, M., DOLAR, M. E., NAK, S. G. (2014). The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 4, 411–415. https://ajindex.com/articles/409491

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Ersöz G, Karasu Z, Akarca US, Yüce G, İlter T, Batur Y. Does blood biochemistry reflect liver histology in chronic viral hepatitis? Turkiye Klinikleri J Gastroenterohepatol 1998
  2. 9(2):80-4 2. Ter Borg F, Ten Kate FJ, Cuypers HT, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 1998
  3. [CrossRef] 3. Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol 2007
  4. [CrossRef] 4. Giustina G, Fattovich G, De Paoli M, et al. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy. Int J Clin Lab Res 1996
  5. [CrossRef] 5. Pontinha N, Pessegueiro H, Barros H. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999
  6. [CrossRef] 6. Murawaki Y, Ikuta Y, Idobe Y. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1999
  7. [CrossRef] 7. Murawaki Y, Nishimura Y, Ikuta Y. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1998
  8. [CrossRef] 8. Aygün C, Gözel N, Demirel U. Kronik viral hepatit B tanısı olan hastalarda serum GGT düzeyi ile karaciğer fibrozu ilişkisi. Fırat Medical Journal 2010
  9. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001
  10. [CrossRef] 10. Vardar R, Vardar E, Demiri S, et al. There any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 2009
  11. Abdo AA. Laboratory predictors of advanced fibrosis in Saudi patients with chronic hepatitis B and C. Saudi J Gastroenterol 2006
  12. [CrossRef] 12. Mossong J, Bill S, Hawotte K. Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers. Bull Soc Sci Med Grand Duche Luxemb 2011
  13. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001
  14. [CrossRef] 14. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without he